| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |